Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
In Vivo (Athens, Greece)|November 6, 2017
Role for Neutrophil Extracellular Traps (NETs) and Platelet Aggregation in Early Sepsis-induced Hepatic DysfunctionKentaro Sakurai, Tomoharu Miyashita, Mitsuyoshi Okazaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[A safely resected case of hypervascular pancreatic giant tumor after preoperative arterial embolization]Atsushi Hirose, Hidehiro Tajima, Koichi Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker]Hirofumi Terakawa, Katsunobu Oyama, Toshifumi Watanabe, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.
Molecular and Clinical Oncology|May 23, 2017
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancerHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.
Oncology Letters|October 19, 2013
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell lineAtsushi Hirose, Hidehiro Tajima, Tetsuo Ohta, et al.
Journal of Gastroenterology|February 22, 2014
Evaluation of serum HER2-ECD levels in patients with gastric cancerKatsunobu Oyama, Sachio Fushida, Tomoya Tsukada, et al.
Pageof 21